The Food and Drug Administration (FDA) has issued a Class II recall for over 7,000 bottles of duloxetine, a popular antidepressant, due to the presence of a potentially carcinogenic chemical.
The PDUFA dates have been pushed for sotorasib and obeticholic acid for metastatic colorectal cancer and primary biliary ...
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.